What is Form FDA 1572, and who needs to sign it?
Form FDA 1572 is the Statement of Investigator: before a US drug study under an IND begins at a site, the sponsor must obtain it signed by the investigator (21 CFR 312.53(c)).
It names the investigator, the protocol, the research facilities, the clinical laboratories, the IRB and the sub-investigators, and it records the investigator's commitments to follow the protocol, personally conduct or supervise the study, and meet the consent, IRB and safety reporting rules (21 CFR 312.53(c)).
What the form contains
- The investigator's name and address (21 CFR 312.53(c)).
- The protocol name and code number (21 CFR 312.53(c)).
- Each medical school, hospital or research facility where the study will be conducted (21 CFR 312.53(c)).
- Any clinical laboratory facilities used in the study (21 CFR 312.53(c)).
- The IRB responsible for review and approval of the study (21 CFR 312.53(c)).
- The investigator's commitments, and a list of sub-investigators such as research fellows and residents (21 CFR 312.53(c)).
What the investigator commits to
- Conduct the study according to the current protocol, changing it only after notifying the sponsor, except to protect subjects (21 CFR 312.53(c)).
- Personally conduct or supervise the investigation (21 CFR 312.53(c)).
- Meet the informed consent rules in Part 50 and the IRB rules in Part 56 (21 CFR 312.53(c)).
- Report adverse experiences to the sponsor (21 CFR 312.53(c)).
- Read and understand the Investigator's Brochure (21 CFR 312.53(c)).
- Make sure everyone assisting knows their obligations (21 CFR 312.53(c)).
When the 1572 needs updating
Because the form lists sub-investigators, sites, laboratories and the IRB, a change to any of those is a reason to tell the sponsor, who decides whether a revised form is needed. Many sites check the 1572 against the delegation log at every staff change, so the two never disagree.
Questions people also ask
Is the 1572 required outside the United States?
The form comes from FDA's IND regulations (21 CFR 312.53(c)). Sites outside the US join a study under an IND only when the sponsor runs it that way, and the sponsor will say whether a 1572 is needed.
Who goes in the sub-investigator section?
The people who assist the investigator in conducting the investigation, for example research fellows and residents (21 CFR 312.53(c)). ICH E6(R3) describes a sub-investigator as a team member performing significant trial procedures or making important trial decisions under the investigator's oversight (ICH E6(R3) Glossary).
Is the 1572 the same as the delegation log?
No. The 1572 is a statement to the sponsor; the delegation log is the site's record of who does which task (ICH E6(R3) 2.3.3). They should agree with each other.
Does a coordinator sign the 1572?
No. The investigator signs it. Coordinators often prepare it and keep it current.
Primary sources
- 21 CFR 312.53: Selecting investigators and monitors (eCFR): https://www.ecfr.gov/current/title-21/section-312.53
- 21 CFR 312.60: General responsibilities of investigators (eCFR): https://www.ecfr.gov/current/title-21/section-312.60
- ICH E6(R3) Guideline for Good Clinical Practice, final version adopted 6 January 2025 (ICH): https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf
Last reviewed
2026-11-12